SlideShare a Scribd company logo
1 of 3
M E H B O O B M E R C H A N T, MBBS, SLS (ASCP)
917 N. Ashbury Ave, Bolingbrook, IL. 60440
Home: 630 910 7626. Cell: 630 456 2659
E-mail: mehboob917@gmail.com
EDUCATION:
M.B., B.S. (Bachelor of Medicine & Bachelor of Surgery), Seth G. S. Medical College & K. E. M. Hospital,
University of Bombay. 1976. (Credentials verified by WES as equivalent to MD).
WORK EXPERIENCE:
1. Quality Assurance Officer. Mathews Center for Cellular Therapy, Northwestern Medicine, Chicago, Illinois
60611. August 2008 to present.
2. Quality & Regulatory Coordinator. Stem Cell Processing & Graft Engineering Laboratory, Lurie Children’s
Hospital of Chicago, Chicago, Illinois 60611. July 2003 to August 2008.
3. Medical Technologist IV. Research. Stem Cell Processing & Graft Engineering Laboratory, Lurie Children’s
Hospital of Chicago, Chicago, Illinois 60611. Jan 2003 to July 2003.
RESPONSIBILITIES/EXPERTISE:
1. In charge of quality, regulatory and compliance functions for the cell therapy laboratory; including, writing
and maintaining SOPs, document control, change control, incident management and corrective/preventive
actions, audits and validation; and review of patient batch record.
2. Re-wrote the entire Standard Operating Manual for the Mathews Center for Cellular Therapy in 2008, from a
Quality, Regulatory and Compliance perspective.
3. Invented a new Event Management & Reporting system for Mathews Center for Cellular Therapy in 2010.
4. Internal and External Inspections and Audits, including CAP, CLIA, FDA, IDPH and FACT.
5. Document and Change Control.
6. Adverse event tracking and trending.
7. Data tracking and trending, especially for events/incidents; post-transplant outcomes and environment
monitoring.
8. Liaise with cell collection (apheresis) and clinical departments.
RESEARCH PRESENTATIONS: (All presentations as First Author)
1. Abstract: Evaluation of 101 Cord Blood Transplants. 2005 ASBMT, Colorado. February 2005.
2. Abstract: Results of Second Transplantations following Umbilical Cord Blood Transplant failure. 2006 ASBMT,
Honolulu. February 2006.
3. Abstract: Correlation between Infused Mononuclear Cells and Transplant Outcome in Pediatric CBT. A Study
of 92 Single CBT. 2007 ASBMT, Keystone. February 2007.
4. Abstract: Comparison of Outcomes in Children undergoing Single Allogeneic Transplantation, using Bone
Marrow (BM) or Umbilical Cord Blood (UCB) as Stem Cell Source. A study of 256 Transplants at Children's
Memorial Hospital, Chicago. 2008 ASBMT, San Diego. February 2008.
5. Abstract: Significance of HLA-B Antigen Mismatch in Event Free Survival & Relapse in Pediatric Umbilical Cord
Blood Transplantation: Experience from 124 Single CBT at Children’s Memorial Hospital, Chicago. 2009
ASBMT, Tampa. February 2009.
6. Oral Abstract: Defining Event Reporting in the Cell Processing Facility. 2010 ASBMT, Orlando. February 2010.
7. Abstract: Does Stored HPC, Apheresis Product Need an Expiration Date? Graft Cell Viability after Long Term
Storage. 2011 ASBMT, Hawaii. February 2011.
8. Abstract: Two Year Evaluation of Event Reporting System for the Cell Therapy Processing Facility. 2011
ASBMT, Hawaii. February 2011.
9. Abstract: Stem Cell Transplant Adverse Reactions (STAR) Analysis: Does a higher Infusion Red Blood Cell
content correlate with serious Adverse Events? ASBMT, San Diego. February 2012.
10. Abstract: Standardizing Standard Operating Procedures Manual to benchmark Cell Processing Facility
Performance. ASBMT, Salt Lake City. February 2013.
11. Abstract: Increased Transplant Related Mortality and poor donor cell chimerism in African American children
undergoing Umbilical Cord Transplantation. ASBMT, Grapevine, Texas. February 2014.
12. Abstract: Addition of Thiotepa to the conditioning regimensignificantly improves transplant outcomes in
children undergoing Umbilical Cord Blood Transplantation for non-malignant disease. ASBMT, Grapevine,
Texas. February 2014.
13. Abstract: Adverse Event during Stem Cell Infusion: A Review of Recently Published Literature. ASBMT, San
Diego, CA. February 2015.
14. Abstract: Does Stored Hematopoietic Stem Cell Product need an Expiration Date? Recipients Engrafted
Despite Infusion of Products Over Five Years in Storage. A Retrospective Evaluation from Northwestern
Memorial Hospital, Chicago. ASBMT, Honolulu, Hawaii. February 2016.
COMMITTEE APPOINTMENTS:
 Dept. of Pathology and Laboratory Medicine, Quality and Safety Committee.
 Stem Cell Transplant Program’s Quality Committee.
 Stem Cell Transplant Program’s Data and CIBMTR Reporting Committee.
MEMBERSHIPS:
 Indian Medical Association, Bombay (Chembur Chapter).
 General Practitioner's Association, Bombay.
 Founder Member. Govandi Medical Association. Bombay.
 ASBMT
 ASCP
LANGUAGES:
Fluent in spoken and written English, besides many Indian languages.
COMPUTER:
 Proficient in MS Excel, Word, PowerPoint and in Internet, Intranet and Databases.
 Special expertise in data analysis.
 Set up StemLab database (Stem Soft, Inc) from scratch for Children’s Memorial Hospital- from writing of
protocols to data entry (retrospective and prospective); Responsible for maintaining, auditing and validating
the same for regulatory purposes.
WORK EXPERIENCE (Prior):
Senior Medical Officer. Centenary Municipal General Hospital, Bombay. A 225 bed City Hospital. 1985 -1998.
Clinical Responsibilities:
Assistant Surgeon, Department of Surgery. Responsibilities involved making daily rounds, perform surgery.
In charge of outpatient surgical clinic. Case load involved Trauma, General Abdominal and Thoracic surgery,
Pediatric surgery, Oncology surgery and Burn surgery. Incharge of STD Clinic, Intensive Care Unit, and
Emergency Wards.
Teaching Responsibilities:
Responsible for interview and resident selection process, teaching rounds, conferences, evaluation and
overseeing residents' activities at the hospital.
Administrative Duties:
As assistant to the medical director, I was the liaison between staff and Departmental Heads. Plan and
develop policies and procedures for Medical, Medico-legal and General Administrative issues. Compile and
analyze reports, communications and data. Organize and actively participate in CME programs, Community
Care, Mass Immunization, and other health welfare programs. Administrative Chief in-charge of Tuberculosis
control program, Operation Rooms, Blood Bank, Intensive Care Unit, and Emergency Rooms. Troubleshoot
and resolve all in-staff problems. Comply with departmental guidelines and protocols, follow and adhere to
organizational standards, policies and procedures. Plan and process disbursement of annual 4.5 million
hospital budget.
RESEARCH (Prior):
 Once A Day Gentamycin: An efficacy study in a medium size urban city hospital.
B.G. Godbole, MS; M. Merchant, MBBS; V. S. Kesarkar, MBBS
 Results of Pre-operative Skin Preparation Using a Single application of Betadine.
B. G. Godbole, MS; M. Merchant, MBBS
 Appendectomy: Non-burial of the stump. A study of 100 cases.
M. Merchant, MBBS; B. G. Godbole, MS
 Tube drain Vs. Corrugated drain: Post-operative infection in Traumatic Abdomen, A study of 12 cases.
B.G. Godbole, MS; M. Merchant, MBBS
COMMITTEE APPOINTMENTS (Prior):
 Vice-chairman: Operation Theatre Protocol Committee, C. M. G. Hospital, Bombay.
 Vice-chairman: Contingency Committee for Management of Plague Epidemic, C. M. G. Hospital, Bombay.
 Chairman: Blood Banking Services Board, C. M. G. Hospital, Bombay.
EXTRA-CURRICULAR ACTIVITIES:
 Secretary, Editor & Publisher- College Newspaper, Bulletin & Magazine.
Seth. G.S.Medical College, Bombay University. 1974-1975
 Secretary, Annual College celebrations and funfair.
Seth G. S. Medical College, Bombay University. 1974
 Student Representative- Golden Jubilee Committee, K.E.M. Hospital, Bombay. 1974
ADDITIONAL TRAINING:
 Current Advances in Tuberculosis Management and Treatment.
Conducted by World Health Organization. Dec. 1995
 HIV and its impact in Asia.
Conducted by The BritishCouncil. Aug. 1995
 Trauma Management Today.
Conducted by Lokmanya Tilak Medical College, Bombay University. Jan. 1991
 Child and Post-partum Mother: Survival and Management.
Conducted by World Health Organization and India Population Project V. April 1989.

More Related Content

What's hot

Emerging collaboration models for academic medical centers _ our place in the...
Emerging collaboration models for academic medical centers _ our place in the...Emerging collaboration models for academic medical centers _ our place in the...
Emerging collaboration models for academic medical centers _ our place in the...Rick Silva
 
Investigating the Correlation between cfDNA and Transplant Rejection/Injury
Investigating the Correlation between cfDNA and Transplant Rejection/InjuryInvestigating the Correlation between cfDNA and Transplant Rejection/Injury
Investigating the Correlation between cfDNA and Transplant Rejection/InjuryJuliane M. Liberto
 
Monitoring the quality of data in the clinical use of pathogen genomes
Monitoring the quality of data in the clinical use of pathogen genomesMonitoring the quality of data in the clinical use of pathogen genomes
Monitoring the quality of data in the clinical use of pathogen genomesHealth Informatics New Zealand
 
IQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimIQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimMark David Lim
 

What's hot (6)

Emerging collaboration models for academic medical centers _ our place in the...
Emerging collaboration models for academic medical centers _ our place in the...Emerging collaboration models for academic medical centers _ our place in the...
Emerging collaboration models for academic medical centers _ our place in the...
 
Investigating the Correlation between cfDNA and Transplant Rejection/Injury
Investigating the Correlation between cfDNA and Transplant Rejection/InjuryInvestigating the Correlation between cfDNA and Transplant Rejection/Injury
Investigating the Correlation between cfDNA and Transplant Rejection/Injury
 
JannaBrancato_Resume
JannaBrancato_ResumeJannaBrancato_Resume
JannaBrancato_Resume
 
Monitoring the quality of data in the clinical use of pathogen genomes
Monitoring the quality of data in the clinical use of pathogen genomesMonitoring the quality of data in the clinical use of pathogen genomes
Monitoring the quality of data in the clinical use of pathogen genomes
 
CV_11May2016
CV_11May2016CV_11May2016
CV_11May2016
 
IQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimIQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - Lim
 

Similar to 2016.CV..MEHBOOB

CURICULUM VITAE 2016
CURICULUM VITAE 2016CURICULUM VITAE 2016
CURICULUM VITAE 2016Azza Kamel
 
Obeid generic_2017-11
Obeid generic_2017-11Obeid generic_2017-11
Obeid generic_2017-11Jihad Obeid
 
Hydroxyurea for the treatment of sickle cell disease2
Hydroxyurea for the treatment of sickle cell disease2Hydroxyurea for the treatment of sickle cell disease2
Hydroxyurea for the treatment of sickle cell disease2alsaeedhh
 
CV of Rong Chen
CV of Rong ChenCV of Rong Chen
CV of Rong ChenRong Chen
 
UC BRAID Biobanking
UC BRAID Biobanking UC BRAID Biobanking
UC BRAID Biobanking CTSI at UCSF
 
CV - Aalap Shah MD
CV - Aalap Shah MDCV - Aalap Shah MD
CV - Aalap Shah MDAalap Shah
 
5th Tumor Models Boston July 2017 Brochure
5th Tumor Models Boston July 2017 Brochure5th Tumor Models Boston July 2017 Brochure
5th Tumor Models Boston July 2017 BrochureDiane McKenna
 
Ben Bushnell Resume 2015
Ben Bushnell Resume 2015Ben Bushnell Resume 2015
Ben Bushnell Resume 2015Ben Bushnell
 
Kamala Maddali Cv2011
Kamala Maddali Cv2011Kamala Maddali Cv2011
Kamala Maddali Cv2011kamalamaddali
 
Downloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docx
Downloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docxDownloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docx
Downloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docxjacksnathalie
 
The Clinical Genome Conference 2014
The Clinical Genome Conference 2014The Clinical Genome Conference 2014
The Clinical Genome Conference 2014Nicole Proulx
 
ResumeNov2016
ResumeNov2016ResumeNov2016
ResumeNov2016emperez2
 
KarenDeBuskMSN04_2016LINKEDIN
KarenDeBuskMSN04_2016LINKEDINKarenDeBuskMSN04_2016LINKEDIN
KarenDeBuskMSN04_2016LINKEDINKaren DeBusk
 
Carlos M. Barrera Resume
Carlos M. Barrera ResumeCarlos M. Barrera Resume
Carlos M. Barrera ResumeCarlos Barrera
 
Maples PB Resume 010417
Maples PB Resume 010417Maples PB Resume 010417
Maples PB Resume 010417Phil Maples
 

Similar to 2016.CV..MEHBOOB (20)

CURICULUM VITAE 2016
CURICULUM VITAE 2016CURICULUM VITAE 2016
CURICULUM VITAE 2016
 
CV Dr P K Gupta
CV Dr P K GuptaCV Dr P K Gupta
CV Dr P K Gupta
 
Obeid generic_2017-11
Obeid generic_2017-11Obeid generic_2017-11
Obeid generic_2017-11
 
DanaM 0116 plus R6
DanaM 0116 plus R6DanaM 0116 plus R6
DanaM 0116 plus R6
 
Hydroxyurea for the treatment of sickle cell disease2
Hydroxyurea for the treatment of sickle cell disease2Hydroxyurea for the treatment of sickle cell disease2
Hydroxyurea for the treatment of sickle cell disease2
 
CV of Rong Chen
CV of Rong ChenCV of Rong Chen
CV of Rong Chen
 
UC BRAID Biobanking
UC BRAID Biobanking UC BRAID Biobanking
UC BRAID Biobanking
 
CV - Aalap Shah MD
CV - Aalap Shah MDCV - Aalap Shah MD
CV - Aalap Shah MD
 
F MADIAI CV_2016
F MADIAI CV_2016F MADIAI CV_2016
F MADIAI CV_2016
 
5th Tumor Models Boston July 2017 Brochure
5th Tumor Models Boston July 2017 Brochure5th Tumor Models Boston July 2017 Brochure
5th Tumor Models Boston July 2017 Brochure
 
Ben Bushnell Resume 2015
Ben Bushnell Resume 2015Ben Bushnell Resume 2015
Ben Bushnell Resume 2015
 
Kamala Maddali Cv2011
Kamala Maddali Cv2011Kamala Maddali Cv2011
Kamala Maddali Cv2011
 
Ortiz CV 12.15.16
Ortiz CV 12.15.16Ortiz CV 12.15.16
Ortiz CV 12.15.16
 
Downloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docx
Downloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docxDownloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docx
Downloaded by XanEdu UserID 656234 on 6302014. Jesse H. Jone.docx
 
The Clinical Genome Conference 2014
The Clinical Genome Conference 2014The Clinical Genome Conference 2014
The Clinical Genome Conference 2014
 
ResumeNov2016
ResumeNov2016ResumeNov2016
ResumeNov2016
 
Kalyan Resume
Kalyan ResumeKalyan Resume
Kalyan Resume
 
KarenDeBuskMSN04_2016LINKEDIN
KarenDeBuskMSN04_2016LINKEDINKarenDeBuskMSN04_2016LINKEDIN
KarenDeBuskMSN04_2016LINKEDIN
 
Carlos M. Barrera Resume
Carlos M. Barrera ResumeCarlos M. Barrera Resume
Carlos M. Barrera Resume
 
Maples PB Resume 010417
Maples PB Resume 010417Maples PB Resume 010417
Maples PB Resume 010417
 

2016.CV..MEHBOOB

  • 1. M E H B O O B M E R C H A N T, MBBS, SLS (ASCP) 917 N. Ashbury Ave, Bolingbrook, IL. 60440 Home: 630 910 7626. Cell: 630 456 2659 E-mail: mehboob917@gmail.com EDUCATION: M.B., B.S. (Bachelor of Medicine & Bachelor of Surgery), Seth G. S. Medical College & K. E. M. Hospital, University of Bombay. 1976. (Credentials verified by WES as equivalent to MD). WORK EXPERIENCE: 1. Quality Assurance Officer. Mathews Center for Cellular Therapy, Northwestern Medicine, Chicago, Illinois 60611. August 2008 to present. 2. Quality & Regulatory Coordinator. Stem Cell Processing & Graft Engineering Laboratory, Lurie Children’s Hospital of Chicago, Chicago, Illinois 60611. July 2003 to August 2008. 3. Medical Technologist IV. Research. Stem Cell Processing & Graft Engineering Laboratory, Lurie Children’s Hospital of Chicago, Chicago, Illinois 60611. Jan 2003 to July 2003. RESPONSIBILITIES/EXPERTISE: 1. In charge of quality, regulatory and compliance functions for the cell therapy laboratory; including, writing and maintaining SOPs, document control, change control, incident management and corrective/preventive actions, audits and validation; and review of patient batch record. 2. Re-wrote the entire Standard Operating Manual for the Mathews Center for Cellular Therapy in 2008, from a Quality, Regulatory and Compliance perspective. 3. Invented a new Event Management & Reporting system for Mathews Center for Cellular Therapy in 2010. 4. Internal and External Inspections and Audits, including CAP, CLIA, FDA, IDPH and FACT. 5. Document and Change Control. 6. Adverse event tracking and trending. 7. Data tracking and trending, especially for events/incidents; post-transplant outcomes and environment monitoring. 8. Liaise with cell collection (apheresis) and clinical departments. RESEARCH PRESENTATIONS: (All presentations as First Author) 1. Abstract: Evaluation of 101 Cord Blood Transplants. 2005 ASBMT, Colorado. February 2005. 2. Abstract: Results of Second Transplantations following Umbilical Cord Blood Transplant failure. 2006 ASBMT, Honolulu. February 2006. 3. Abstract: Correlation between Infused Mononuclear Cells and Transplant Outcome in Pediatric CBT. A Study of 92 Single CBT. 2007 ASBMT, Keystone. February 2007. 4. Abstract: Comparison of Outcomes in Children undergoing Single Allogeneic Transplantation, using Bone Marrow (BM) or Umbilical Cord Blood (UCB) as Stem Cell Source. A study of 256 Transplants at Children's Memorial Hospital, Chicago. 2008 ASBMT, San Diego. February 2008. 5. Abstract: Significance of HLA-B Antigen Mismatch in Event Free Survival & Relapse in Pediatric Umbilical Cord Blood Transplantation: Experience from 124 Single CBT at Children’s Memorial Hospital, Chicago. 2009 ASBMT, Tampa. February 2009. 6. Oral Abstract: Defining Event Reporting in the Cell Processing Facility. 2010 ASBMT, Orlando. February 2010. 7. Abstract: Does Stored HPC, Apheresis Product Need an Expiration Date? Graft Cell Viability after Long Term Storage. 2011 ASBMT, Hawaii. February 2011. 8. Abstract: Two Year Evaluation of Event Reporting System for the Cell Therapy Processing Facility. 2011 ASBMT, Hawaii. February 2011. 9. Abstract: Stem Cell Transplant Adverse Reactions (STAR) Analysis: Does a higher Infusion Red Blood Cell content correlate with serious Adverse Events? ASBMT, San Diego. February 2012. 10. Abstract: Standardizing Standard Operating Procedures Manual to benchmark Cell Processing Facility Performance. ASBMT, Salt Lake City. February 2013.
  • 2. 11. Abstract: Increased Transplant Related Mortality and poor donor cell chimerism in African American children undergoing Umbilical Cord Transplantation. ASBMT, Grapevine, Texas. February 2014. 12. Abstract: Addition of Thiotepa to the conditioning regimensignificantly improves transplant outcomes in children undergoing Umbilical Cord Blood Transplantation for non-malignant disease. ASBMT, Grapevine, Texas. February 2014. 13. Abstract: Adverse Event during Stem Cell Infusion: A Review of Recently Published Literature. ASBMT, San Diego, CA. February 2015. 14. Abstract: Does Stored Hematopoietic Stem Cell Product need an Expiration Date? Recipients Engrafted Despite Infusion of Products Over Five Years in Storage. A Retrospective Evaluation from Northwestern Memorial Hospital, Chicago. ASBMT, Honolulu, Hawaii. February 2016. COMMITTEE APPOINTMENTS:  Dept. of Pathology and Laboratory Medicine, Quality and Safety Committee.  Stem Cell Transplant Program’s Quality Committee.  Stem Cell Transplant Program’s Data and CIBMTR Reporting Committee. MEMBERSHIPS:  Indian Medical Association, Bombay (Chembur Chapter).  General Practitioner's Association, Bombay.  Founder Member. Govandi Medical Association. Bombay.  ASBMT  ASCP LANGUAGES: Fluent in spoken and written English, besides many Indian languages. COMPUTER:  Proficient in MS Excel, Word, PowerPoint and in Internet, Intranet and Databases.  Special expertise in data analysis.  Set up StemLab database (Stem Soft, Inc) from scratch for Children’s Memorial Hospital- from writing of protocols to data entry (retrospective and prospective); Responsible for maintaining, auditing and validating the same for regulatory purposes. WORK EXPERIENCE (Prior): Senior Medical Officer. Centenary Municipal General Hospital, Bombay. A 225 bed City Hospital. 1985 -1998. Clinical Responsibilities: Assistant Surgeon, Department of Surgery. Responsibilities involved making daily rounds, perform surgery. In charge of outpatient surgical clinic. Case load involved Trauma, General Abdominal and Thoracic surgery, Pediatric surgery, Oncology surgery and Burn surgery. Incharge of STD Clinic, Intensive Care Unit, and Emergency Wards. Teaching Responsibilities: Responsible for interview and resident selection process, teaching rounds, conferences, evaluation and overseeing residents' activities at the hospital. Administrative Duties: As assistant to the medical director, I was the liaison between staff and Departmental Heads. Plan and develop policies and procedures for Medical, Medico-legal and General Administrative issues. Compile and analyze reports, communications and data. Organize and actively participate in CME programs, Community Care, Mass Immunization, and other health welfare programs. Administrative Chief in-charge of Tuberculosis
  • 3. control program, Operation Rooms, Blood Bank, Intensive Care Unit, and Emergency Rooms. Troubleshoot and resolve all in-staff problems. Comply with departmental guidelines and protocols, follow and adhere to organizational standards, policies and procedures. Plan and process disbursement of annual 4.5 million hospital budget. RESEARCH (Prior):  Once A Day Gentamycin: An efficacy study in a medium size urban city hospital. B.G. Godbole, MS; M. Merchant, MBBS; V. S. Kesarkar, MBBS  Results of Pre-operative Skin Preparation Using a Single application of Betadine. B. G. Godbole, MS; M. Merchant, MBBS  Appendectomy: Non-burial of the stump. A study of 100 cases. M. Merchant, MBBS; B. G. Godbole, MS  Tube drain Vs. Corrugated drain: Post-operative infection in Traumatic Abdomen, A study of 12 cases. B.G. Godbole, MS; M. Merchant, MBBS COMMITTEE APPOINTMENTS (Prior):  Vice-chairman: Operation Theatre Protocol Committee, C. M. G. Hospital, Bombay.  Vice-chairman: Contingency Committee for Management of Plague Epidemic, C. M. G. Hospital, Bombay.  Chairman: Blood Banking Services Board, C. M. G. Hospital, Bombay. EXTRA-CURRICULAR ACTIVITIES:  Secretary, Editor & Publisher- College Newspaper, Bulletin & Magazine. Seth. G.S.Medical College, Bombay University. 1974-1975  Secretary, Annual College celebrations and funfair. Seth G. S. Medical College, Bombay University. 1974  Student Representative- Golden Jubilee Committee, K.E.M. Hospital, Bombay. 1974 ADDITIONAL TRAINING:  Current Advances in Tuberculosis Management and Treatment. Conducted by World Health Organization. Dec. 1995  HIV and its impact in Asia. Conducted by The BritishCouncil. Aug. 1995  Trauma Management Today. Conducted by Lokmanya Tilak Medical College, Bombay University. Jan. 1991  Child and Post-partum Mother: Survival and Management. Conducted by World Health Organization and India Population Project V. April 1989.